CoinDesk Research maps five crypto privacy approaches and examines which models hold up as AI improves. Full coverage of ...
Had they included just one of Tony Hoare’s achievements, many scientific careers would be considered prestigious enough. His ...
Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free energy perturbation (FEP) calculations but at ...
Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing 3 ...
Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...
Salt Lake City, UT, April 22, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data ...
PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading ...
The pharmaceutical industry is on the cusp of an AI-driven revolution. By 2030, AI-powered drug discovery is projected to be a $9.1 billion market, growing at a staggering 29.7% CAGR. AI promises to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results